Need of Epigenetic Biomarkers

    The epigenome describes to the complete description of all potentially heritable modifications of the genome without any changes in primary DNA sequences. Epigenetic biomarkers can be widely defined as measurable modifications of the genome with preserved DNA sequence.

    Epigenetic manupulation and regulators represent potential molecular elements which control relevant physiological and pathological features, thereby contributing to the natural history of human disease. These epigenetic modulators can be used as disease biomarkers, since they show several advantages and provide information about gene function, thus explaining differences among patient endophenotypes.

    Noninvasive Epigenetic Markers can be used as biomarkers for the molecular diagnosis of following cancer:

  • Prostate Cancer
  • Bladder Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer

Related Conference of Need of Epigenetic Biomarkers

September 27-28, 2021

15th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
October 18-19, 2021

20th International Conference on Structural Biology

Rome, Italy
December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia

Need of Epigenetic Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in